Trial
NCT01334099
Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Health Network, Toronto
Collaborators
—
Condition
Metastatic Breast Cancer
Intervention
CP-675,206
Why stopped
Contract with drug supplier expired and was not renewed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-22